| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.616 | 22.694 | 41.548 | 55.592 | 67.825 | 96.571 | 106.377 |
| Total Income - EUR | - | - | - | 4.616 | 22.694 | 43.616 | 55.595 | 67.827 | 96.577 | 106.392 |
| Total Expenses - EUR | - | - | - | 3.515 | 17.551 | 23.196 | 23.930 | 28.873 | 28.815 | 36.251 |
| Gross Profit/Loss - EUR | - | - | - | 1.101 | 5.144 | 20.420 | 31.664 | 38.954 | 67.762 | 70.141 |
| Net Profit/Loss - EUR | - | - | - | 1.025 | 4.873 | 20.145 | 31.208 | 38.378 | 66.941 | 67.333 |
| Employees | - | - | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Albadamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 47 | 0 | 1.177 | 884 | 1.407 | 976 | 1.933 |
| Current Assets | - | - | - | 1.499 | 7.054 | 22.497 | 31.996 | 38.895 | 68.667 | 69.556 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 2.566 | 15.667 | 24.113 | 26.831 | 38.745 | 42.777 |
| Cash | - | - | - | 1.499 | 4.488 | 6.830 | 7.884 | 12.064 | 29.922 | 26.779 |
| Shareholders Funds | - | - | - | 1.068 | 5.920 | 20.247 | 31.316 | 38.564 | 67.179 | 67.594 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 479 | 1.133 | 3.427 | 1.564 | 1.738 | 2.465 | 3.895 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Albadamed S.r.l.